Sector News

Linde buys U.S.-based respiratory therapies specialist

December 7, 2015
Chemical Value Chain

(Reuters) – German industrial gases maker Linde (LING.DE) said on Monday it agreed to acquire U.S.-based respiratory therapies specialist American HomePatient [HIAAMA.UL] from Highland Capital Management LP.

No financial details were disclosed.

The deal is expected to close in the first quarter of 2016.

American HomePatient had sales of about 260 million euros ($282 million) in the last financial year.

($1 = 0.9231 euros)

(Reporting by Christoph Steitz; Editing by James Regan)

comments closed

Related News

October 2, 2022

Trinseo announces potential closure of Boehlen, Germany Styrene Plant

Chemical Value Chain

Trinseo (NYSE: TSE), a specialty material solutions provider, announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland GmbH regarding the potential closure of its styrene monomer production site in Boehlen, Germany.

October 2, 2022

Celeste Mastin appointed H.B. Fuller President and CEO, succeeding Jim Owens upon his retirement

Chemical Value Chain

H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s President and Chief Executive Officer, effective December 4, 2022. Upon assuming the role, Mastin will also join the Company’s Board of Directors, replacing Owens, who will be retiring.

October 2, 2022

LyondellBasell realigns executive team, forms circular and low-carbon solutions business

Chemical Value Chain

New LyondellBasell CEO Peter Vanacker, who joined the company from Neste in May, today named his senior executive team and outlined organizational changes, including creation of a circular and low-carbon solutions business. All changes will be effective 1 October.